|
|
Left ventricular mass (gm);
mean (sd)
|
150.1 |
(32.1) |
Age (years);
mean (sd)
|
55.7 |
(5.6) |
Female;
n (%)
|
495 |
(68.7) |
ApoE ε4 allele presence;
n (%)
|
170 |
(23.6) |
Income;
n (%)
|
|
|
Less than $10,000 |
195 |
(33.6) |
$10,000 to less than $25,000 |
253 |
(43.5) |
$25,000 or greater |
133 |
(22.9) |
Education (number of years);
mean (sd)
|
12.4 |
(2.9) |
Study Site;
n (%)
|
|
|
Arizona |
88 |
(12.2) |
Oklahoma |
305 |
(42.3) |
Dakotas |
328 |
(45.5) |
Smoking status;
n (%)
|
|
|
Never |
202 |
(28.8) |
Ever |
263 |
(37.5) |
Current |
236 |
(33.7) |
Alcohol use status;
n (%)
|
|
|
Never |
137 |
(19.3) |
Ever |
339 |
(47.7) |
Current |
234 |
(33.0) |
Perceived stress scale (PSS);
mean (sd)
|
10.8 |
(4.4) |
BMI (kg/m2);
mean (sd)
|
31.5 |
(5.8) |
BMI (CDC);
n (%)
|
|
|
Normal |
83 |
(11.5) |
Overweight |
234 |
(32.5) |
Obese |
402 |
(55.9) |
Systolic blood pressure (mmHg);
mean (sd)
|
123.3 |
(16.4) |
Diastolic blood pressure (mmHg);
mean (sd)
|
74.8 |
(9.3) |
Heart disease;
n (%)
|
86 |
(11.9) |
Atrial fibrillation;
n (%)
|
1 |
(0.1) |
Hypertension;
n (%)
|
225 |
(31.2) |
Treatment for Hypertension;
n (%)
|
154 |
(21.4) |
Diabetes;
n (%)
|
211 |
(29.3) |
Treatment for diabetes;
n (%)
|
|
|
None |
589 |
(92.8) |
Oral |
0 |
(0.0) |
Insulin |
44 |
(6.9) |
Oral/Insulin |
2 |
(0.3) |